메뉴 건너뛰기




Volumn 34, Issue 1, 2013, Pages 297-305

Impact of the 2008-2012 french Alzheimer plan on the use of cerebrospinal fluid biomarkers in research memory center: The PLM study

Author keywords

Alzheimer's disease; amyloid peptides; cerebrospinal fluid biomarkers; cohort studies; dementia; p tau

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; P TAU PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

EID: 84874312063     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-121549     Document Type: Article
Times cited : (50)

References (45)
  • 9
    • 84856548921 scopus 로고    scopus 로고
    • Multicenter study on lumbar puncture indication, clinical practice and feasibility
    • Paquet C, Latour F, Saulnier I, Hanon O (2012) Multicenter study on lumbar puncture indication, clinical practice and feasibility. Rev Neurol (Paris) 168, 28-32.
    • (2012) Rev Neurol (Paris) , vol.168 , pp. 28-32
    • Paquet, C.1    Latour, F.2    Saulnier, I.3    Hanon, O.4
  • 17
    • 62449262536 scopus 로고    scopus 로고
    • Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain
    • Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttila T (2009) Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol 66, 382-389.
    • (2009) Arch Neurol , vol.66 , pp. 382-389
    • Tapiola, T.1    Alafuzoff, I.2    Herukka, S.K.3    Parkkinen, L.4    Hartikainen, P.5    Soininen, H.6    Pirttila, T.7
  • 18
    • 77949423619 scopus 로고    scopus 로고
    • Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
    • Blennow K, Hampel H, Weiner M, Zetterberg H (2010) Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol 6, 131-144.
    • (2010) Nat Rev Neurol , vol.6 , pp. 131-144
    • Blennow, K.1    Hampel, H.2    Weiner, M.3    Zetterberg, H.4
  • 19
    • 70350492571 scopus 로고    scopus 로고
    • Cerebrospinal fluid biomarkers for Alzheimer's disease
    • BlennowK, Zetterberg H (2009) Cerebrospinal fluid biomarkers for Alzheimer's disease. J Alzheimers Dis 18, 413-417.
    • (2009) J Alzheimers Dis , vol.18 , pp. 413-417
    • Blennow, K.1    Zetterberg, H.2
  • 21
    • 7444253126 scopus 로고    scopus 로고
    • Cerebrospinal Fluid Protein Biomarkers for Alzheimer's Disease
    • DOI 10.1602/neurorx.1.2.213, PII S1545534306700372, Biomarkers and Surrogates
    • Blennow K (2004) Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 1, 213-225. (Pubitemid 46589353)
    • (2004) NeuroRx , vol.1 , Issue.2 , pp. 213-225
    • Blennow, K.1
  • 25
    • 0034764622 scopus 로고    scopus 로고
    • Clinical and pathological diagnosis of frontotemporal dementia: Report of the work group on Frontotemporal Dementia and Pick's Disease
    • McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ (2001) Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 58, 1803-1809. (Pubitemid 33044246)
    • (2001) Archives of Neurology , vol.58 , Issue.11 , pp. 1803-1809
    • McKhann, G.M.1    Albert, M.S.2    Grossman, M.3    Miller, B.4    Dickson, D.5    Trojanowski, J.Q.6
  • 28
    • 84880188930 scopus 로고    scopus 로고
    • Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
    • McKeith IG (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB InternationalWorkshop. J Alzheimers Dis 9, 417-423. (Pubitemid 44253336)
    • (2006) Journal of Alzheimer's Disease , vol.9 , Issue.SUPPL. 3 , pp. 417-423
    • McKeith, I.G.1
  • 31
    • 0023710206 scopus 로고
    • Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach
    • DeLong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: A nonparametric approach. Biometrics 44, 837-845.
    • (1988) Biometrics , vol.44 , pp. 837-845
    • Delong, E.R.1    Delong, D.M.2    Clarke-Pearson, D.L.3
  • 37
    • 0035261534 scopus 로고    scopus 로고
    • CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies
    • DOI 10.1007/s100720170055
    • Parnetti L, Lanari A, Amici S, Gallai V, Vanmechelen E, Hulstaert F (2001) CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau international study group. Neurol Sci 22, 77-78. (Pubitemid 33622091)
    • (2001) Neurological Sciences , vol.22 , Issue.1 , pp. 77-78
    • Parnetti, L.1    Lanari, A.2    Amici, S.3    Gallai, V.4    Vanmechelen, E.5    Hulstaert, F.6
  • 39
    • 49949152222 scopus 로고    scopus 로고
    • Cerebral amyloid angiopathy in Lewy body disease
    • Jellinger KA, Attems J (2008) Cerebral amyloid angiopathy in Lewy body disease. J Neural Transm 115, 473-482.
    • (2008) J Neural Transm , vol.115 , pp. 473-482
    • Jellinger, K.A.1    Attems, J.2
  • 40
    • 57349155143 scopus 로고    scopus 로고
    • Posterior cortical atrophy: A rare form of dementia with in vivo evidence of amyloid-beta accumulation
    • Tenovuo O, Kemppainen N, Aalto S, Nagren K, Rinne JO (2008) Posterior cortical atrophy: A rare form of dementia with in vivo evidence of amyloid-beta accumulation. J Alzheimers Dis 15, 351-355.
    • (2008) J Alzheimers Dis , vol.15 , pp. 351-355
    • Tenovuo, O.1    Kemppainen, N.2    Aalto, S.3    Nagren, K.4    Rinne, J.O.5
  • 44
    • 0034650710 scopus 로고    scopus 로고
    • Mild cognitive impairment: Conceptual basis and current nosological status
    • Ritchie K, Touchon J (2000) Mild cognitive impairment: Conceptual basis and current nosological status. Lancet 355, 225-228. (Pubitemid 30068229)
    • (2000) Lancet , vol.355 , Issue.9199 , pp. 225-228
    • Ritchie, K.1    Touchon, J.2
  • 45
    • 78349287910 scopus 로고    scopus 로고
    • The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia
    • Spies PE, Slats D, Sjogren JM, Kremer BP, Verhey FR, Rikkert MG, Verbeek MM (2010) The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia. Curr Alzheimer Res 7, 470-476.
    • (2010) Curr Alzheimer Res , vol.7 , pp. 470-476
    • Spies, P.E.1    Slats, D.2    Sjogren, J.M.3    Kremer, B.P.4    Verhey, F.R.5    Rikkert, M.G.6    Verbeek, M.M.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.